FindMyKOL
Clinical trialNCT02087293UnknownInterventional

e-Pharmacovigilance II - Surveillance for Safety and Effectiveness - Calling for Earlier Detection of Adverse Reactions

NCT02087293 is an interventional trial sponsored by Brigham and Women's Hospital. As of 18 Nov 2026, it has a status the registry marks as unknown. It studies Depression, Diabetes and 2 more conditions. The registry lists an enrollment of 38,400 participants at 1 site in 1 country. The registry lists a start date of 30 Jun 2013 and a primary completion date of 31 Mar 2015.

SponsorBrigham and Women's Hospital →Enrollment38,400DepressionDiabetesHypertensionInsomnia
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT02087293
FieldValue
Registry IDNCT02087293
StatusUnknown
Study typeInterventional trial
Lead sponsorBrigham and Women's Hospital
Enrollment38,400
Registered sites1
Countries1
ConditionsDepression, Diabetes, Hypertension and Insomnia
Start30 Jun 2013
Primary completion31 Mar 2015
Study completion31 Aug 2016
Last update posted4 Aug 2015

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Specific Aim 1: To develop a patient-reported, EHR-integrated system to actively monitor the safety and effectiveness of treatment for patients taking FDA-approved medications for one of four common chronic conditions (diabetes, hypertension, insomnia, depression), with integrated management support by a pharmacist. Specific Aim 2: To measure the reach, effectiveness, adoption and implementation of this integrated module for adult primary care patients in the Brigham and Women's Primary Care Practice-Based Research Network.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Massachusetts, United States1 site
  • Brigham and Women's Hospital

    Boston

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew YorkNYMassachusetts: 1 siteMA1Rhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT02087293

Each answer restates registry values shown on this page.

What is NCT02087293?

NCT02087293 is an interventional trial sponsored by Brigham and Women's Hospital. It studies Depression, Diabetes and 2 more conditions.

Who leads NCT02087293?

The registry names Gordon Schiff, MD (principal investigator, Brigham and Women's Hospital) as the overall official.

Where does NCT02087293 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.

When is NCT02087293 expected to complete?

The registry lists a primary completion date of 31 Mar 2015 and a study completion date of 31 Aug 2016. The sponsor last updated the record on 4 Aug 2015.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.